Amy Tilley
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 4
- HER2/EGFR in Cancer Research 4
- Cancer Treatment and Pharmacology 2
- Peptidase Inhibition and Analysis 1
- Cancer-related Molecular Pathways 1
-
- Advanced Breast Cancer Therapies 2
- Prostate Cancer Treatment and Research 1
- Co-authors
- Richard Pazdur (5 shared papers)Shenghui Tang (4 shared papers)Amna Ibrahim (4 shared papers)Robert Justice (3 shared papers)Suparna Wedam (2 shared papers)Laleh Amiri‐Kordestani (2 shared papers)Patricia Cortazar (2 shared papers)Lijun Zhang (2 shared papers)
- Journals
- Clinical Cancer Research (5 papers)
- Partner nations
- United States
In The Last Decade
Amy Tilley
5 papers receiving 438 citations
Peers
Comparison fields: 5 of 51
- Oncology 309
- Cancer Research 96
- Pulmonary and Respiratory Medicine 207
- Radiology, Nuclear Medicine and Imaging 111
- Genetics 39
Countries citing papers authored by Amy Tilley
This map shows the geographic impact of Amy Tilley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Tilley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Tilley more than expected).
Fields of papers citing papers by Amy Tilley
This network shows the impact of papers produced by Amy Tilley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Tilley. The network helps show where Amy Tilley may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Tilley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 114 | |
| 2 | 2016 | 104 | |
| 3 | 2013 | 89 | |
| 4 | 2018 | 88 | |
| 5 | 2013 | 49 |
About Amy Tilley
Amy Tilley is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Infectious Diseases, having authored 5 papers that have together received 444 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (2 papers), Cancer Treatment and Pharmacology (2 papers), Peptidase Inhibition and Analysis (1 paper), Breast Cancer Treatment Studies (1 paper), Prostate Cancer Treatment and Research (1 paper), Cancer-related Molecular Pathways (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Oncology (309 citations), Cancer Research (96 citations), Pulmonary and Respiratory Medicine (207 citations), Radiology, Nuclear Medicine and Imaging (111 citations) and Genetics (39 citations). Amy Tilley has collaborated with scholars based in United States. Frequent co-authors include Richard Pazdur, Shenghui Tang, Amna Ibrahim, Robert Justice, Suparna Wedam, Laleh Amiri‐Kordestani, Patricia Cortazar, Lijun Zhang, Todd R. Palmby and Rajeshwari Sridhara. Their work appears in journals such as Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.